Cargando…
Organ-on-a-chip: the next generation platform for risk assessment of radiobiology
Organ-on-a-chip devices have been widely used in biomedical science and technology, for example for experimental regenerative medicine and precision healthcare. The main advantage of organ-on-a-chip technology is the facility to build a specific human model that has functional responses on the level...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057494/ https://www.ncbi.nlm.nih.gov/pubmed/35515392 http://dx.doi.org/10.1039/d0ra05173j |
_version_ | 1784697909239873536 |
---|---|
author | Quan, Yi Sun, Miao Tan, Zhaoyi Eijkel, Jan C. T. van den Berg, Albert van der Meer, Andries Xie, Yanbo |
author_facet | Quan, Yi Sun, Miao Tan, Zhaoyi Eijkel, Jan C. T. van den Berg, Albert van der Meer, Andries Xie, Yanbo |
author_sort | Quan, Yi |
collection | PubMed |
description | Organ-on-a-chip devices have been widely used in biomedical science and technology, for example for experimental regenerative medicine and precision healthcare. The main advantage of organ-on-a-chip technology is the facility to build a specific human model that has functional responses on the level of organs or tissues, thereby avoiding the use of animal models, as well as greatly improving new drug discovery processes for personal healthcare. An emerging application domain for organs-on-chips is the study of internal irradiation for humans, which faces the challenges of the lack of a clear model for risk estimation of internal irradiation. We believe that radiobiology studies will benefit from organ-on-a-chip technology by building specific human organ/tissues in vitro. In this paper, we briefly reviewed the state-of-the-art in organ-on-a-chip research in different domains, and conclude with the challenges of radiobiology studies at internal low-dose irradiation. Organ-on-a-chip technology has the potential to significantly improve the radiobiology study as it can mimic the function of human organs or tissues, and here we summarize its potential benefits and possible breakthrough areas, as well as its limitations in internal low-dose radiation studies. |
format | Online Article Text |
id | pubmed-9057494 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Royal Society of Chemistry |
record_format | MEDLINE/PubMed |
spelling | pubmed-90574942022-05-04 Organ-on-a-chip: the next generation platform for risk assessment of radiobiology Quan, Yi Sun, Miao Tan, Zhaoyi Eijkel, Jan C. T. van den Berg, Albert van der Meer, Andries Xie, Yanbo RSC Adv Chemistry Organ-on-a-chip devices have been widely used in biomedical science and technology, for example for experimental regenerative medicine and precision healthcare. The main advantage of organ-on-a-chip technology is the facility to build a specific human model that has functional responses on the level of organs or tissues, thereby avoiding the use of animal models, as well as greatly improving new drug discovery processes for personal healthcare. An emerging application domain for organs-on-chips is the study of internal irradiation for humans, which faces the challenges of the lack of a clear model for risk estimation of internal irradiation. We believe that radiobiology studies will benefit from organ-on-a-chip technology by building specific human organ/tissues in vitro. In this paper, we briefly reviewed the state-of-the-art in organ-on-a-chip research in different domains, and conclude with the challenges of radiobiology studies at internal low-dose irradiation. Organ-on-a-chip technology has the potential to significantly improve the radiobiology study as it can mimic the function of human organs or tissues, and here we summarize its potential benefits and possible breakthrough areas, as well as its limitations in internal low-dose radiation studies. The Royal Society of Chemistry 2020-10-28 /pmc/articles/PMC9057494/ /pubmed/35515392 http://dx.doi.org/10.1039/d0ra05173j Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by-nc/3.0/ |
spellingShingle | Chemistry Quan, Yi Sun, Miao Tan, Zhaoyi Eijkel, Jan C. T. van den Berg, Albert van der Meer, Andries Xie, Yanbo Organ-on-a-chip: the next generation platform for risk assessment of radiobiology |
title | Organ-on-a-chip: the next generation platform for risk assessment of radiobiology |
title_full | Organ-on-a-chip: the next generation platform for risk assessment of radiobiology |
title_fullStr | Organ-on-a-chip: the next generation platform for risk assessment of radiobiology |
title_full_unstemmed | Organ-on-a-chip: the next generation platform for risk assessment of radiobiology |
title_short | Organ-on-a-chip: the next generation platform for risk assessment of radiobiology |
title_sort | organ-on-a-chip: the next generation platform for risk assessment of radiobiology |
topic | Chemistry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057494/ https://www.ncbi.nlm.nih.gov/pubmed/35515392 http://dx.doi.org/10.1039/d0ra05173j |
work_keys_str_mv | AT quanyi organonachipthenextgenerationplatformforriskassessmentofradiobiology AT sunmiao organonachipthenextgenerationplatformforriskassessmentofradiobiology AT tanzhaoyi organonachipthenextgenerationplatformforriskassessmentofradiobiology AT eijkeljanct organonachipthenextgenerationplatformforriskassessmentofradiobiology AT vandenbergalbert organonachipthenextgenerationplatformforriskassessmentofradiobiology AT vandermeerandries organonachipthenextgenerationplatformforriskassessmentofradiobiology AT xieyanbo organonachipthenextgenerationplatformforriskassessmentofradiobiology |